We would love to hear your thoughts about our site and services, please take our survey here.
Ivy ... Scancells products are Global
Collaborations are Global
Its not just about the US indeed .... we may see Chinese involvement
things are changing because Scancell 's ip has changed, so this is not about USA stalled ... its about Scancell going GLobal
with its out look
first 2015
second
2017
https://www.scancell.co.uk/Data/Sites/1/media/publications/posters/poster-1-conference-mainz-sept-17.pdf
https://www.scancell.co.uk/Data/Sites/1/media/publications/posters/pivac-moditope-poster-2.pdf
adjuvants
Burble .... found it
https://flinn.org/immuneregen-biosciences-drug-candidate-homspera-confirms-efficacy/
Burble ... Amplivant has access to moditope ... everytime scancell has used third party product and then had issues of supply .. they can do work arounds ...
Homospera used with Immunobody ... have to check the spelling .. they went into admin ... Scancell then developed a work round
lets try it another way .......... Burble will agree with this ....
Oxford and bioNtech produced a vaccine based only on the genome ... issued by the Chinese labs
Scancell has the genome for the targets for Modiope .... you can see the structures ...
why does BioNtech and Oxford ... generate antibodies against what was a genome .. a 3d model ...
if you actually stop and think about it ........... Pre clinical actually gives you all the data that identify's risk
Lindy solved the problem of Low Avidity
Lindy feels she has solved the problem of Suppression and inflammation using Amplivant added to the moditope peptides
so i am positive what comes next just like Biontech and Oxford is ... Efficacy and Safety
.. and that sets the bench mark for approval
slightly different for cancer as that kills 100% of those failing treatment ...
Disagree ... you cannot Buy Lindy and the Academics
and the Likes of Redmile and Vulpes understand that
because of the stream of Inventions that continue coming out of Scancell why would you sell the Tap ?
and why would you sell "Moditope" at the start of its journey ....
it would be like you have just sold the rights to the PD-1 ligand before you understood its potential ........ it probably a $800 billion asset ... just one product keytruda generates 17% of Mercks sales
Scancell Moditope is way bigger